Well done SPL and Scripps Institute. This product was expected to produce rivers of. Target our investor community with our. Application for quotation of securities - SPL. 40. 83453. ASX - By Stock. Within a post on another SPL thread, sarge17 said: "I wonder what polished horse turd of an announcement we will get from Starpharma in the final days leading up to the AGM. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. 0¢. 1. 0¢. They are the future as also mentioned regularly by Eric Topol. ASX - Short Term Trading. . Can anybody load up the most recent Bell Potter Analysis on SPL? I am unable to source it thanks. Created with Sketch. Firstly, I’m a big fan of SPL and proud of all of their achievements to date (even picked up a few more shares the other day). ASX - General. Created with Sketch. 0. Twenty years later it’s 84. We would like to show you a description here but the site won’t allow us. Contacts. Created with Sketch. Talk with one of our capital. Last updated 14. HotCopper has news,. Join the HotCopper ASX share market forum today for free. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. Time flies. . Twelve month SPL daily chartSame old trend continues. To me, that totally. Market . Join the HotCopper ASX share market forum today for free. . Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. A trader who used stock forum HotCopper to pump and dump about 20 penny stocks using 13 trading accounts has been given a jail term of 2½ years, but is being released immediately on a five-year. Share Given the current status of Starpharma, I am surprised any of these made it through from 2020 but it appears 121,082 did. by other companies i meant those associated with SPL, and ask what up from their end. Then you have the obvious issues with distribution with Lloydsand possiblly really cheap deal with Vietnam let alone teh mysterious India ,. it's a mess with multiple Substantial Holders dumping like this all while HQ remain. We have oft heard the CEO brag about the $1B+ value of the AZD0466 milestones and license revenues. It totally unrealistic that Merck will enter the clinic in 4-5 months. 70. Volume. Last updated 15. . 8985. 36pm 23/11/2023 ? HotCopper has news, discussion, prices and market data on SPARC TECHNOLOGIES LIMITED. ASX - Day TradingSo ton of quistions to answer for CEO and Board most of them already posed so does she follow past format by putting out an update today that she can. 26. Release Date: 27/06/22 09:19; Summary: SPL signs expanded DEP research agreement with US Biopharma; Price Sensitive: Yes; Download Document 194. One of those is worse that SPL. bc. . 0. It’s unlikely to happen, but personally I hope Rob Thomas and Jackie Fairley fall on their sword prior to the AGM. Target our investor community with our suite of Hotcopper Advertising opportunities. Latest Posts. All that seems to happen is that new verses are sometimes added. Forums. 5. Altech Batteries (ASX:ATC) has confirmed its Silumina Anodes project can be eight times larger than previously thought. Share Google Eddy Sunarto to read article about Starpharma stopping the next disease outbreak this is a great article about Viraleze the comments from CEO Jackie Fairley may suggest she is already aware of the results coming out of London imo. Commodities. For a small cap like spl where the revenue stream created would be very large in the context of our current. Resolutons 2,3 &4. Created with Sketch. 4¢. but hey don't take my word for it, see for yourself in the official SPL ASX announcement dated 17th April 2023 You would think that somewhere SPL woudl have commented that TGA is awaiting data from UK trial. ASX - Day TradingThe short position has been negligible in Starpharma since we go booted from the ASX300 and the shorts were able to cover a large portion of their position at rock bottom share prices in the re-balance. Latest Posts. are either confused or talking nonsense. Created with Sketch. I visited their offices in Melbourne near the Alfred a few times and thought they were on to some pretty neat tech. Along with SPL's seemingly better ADC compared to AZ's Enhertu, perhaps Pascal Soriot is wondering if he jumped into bed with the the wrong partner in Daiichi-Sankyo. So the Scripps evidence of efficacy will be the main basis for the decision. Their IP doesn't last forever - you need to hustle in pharma. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. As of 2015, HotCopper was in the top 170 websites in Australia and was. it certainly is a confidence booster to keep on topping upGood luck with whatever investments you may hold at the moment, and if you’re still in SPL, hopefully it will get a bit of a bounce soon. 5. Forums. ASX - Day TradingGood to see another Aussie biotech who has been in communication with the FDA over the last 2 years since receiving a CRL have had their BLA resubmission accepted by the FDA. Created with Sketch. ASX - Day TradingShare Can you point out what you believe are their failings with respect to regulatory filings for a "medical device"? Also do you consider that government and regulatory sentiment may have had an impact on consumer demand and any advertising plan - its clear that Governments are still fixated on Vaccination to the disregard of any. Hope that SPL starts to deliver on its promises. The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial ReviewAbout this app. 5¢. I wonder if LLoyds are taking the pain on 50% off or if SPL rebating just to get volume and name in market ? LLoyds depending on agreemnet would usually just return stock IMO. 5230. ASX - Day TradingLet's face it SPL is a very small investment for most of the institutions, they work on the basis of having a portfolio of these "penny dreadfuls" and expect some to come good but most to fail. ASX - Day Trading. ,), Okamoto, LifeStyles, Aspen and Mundipharma. RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. 00 and $5. . ASX - By Stock. 36. Jackie Fairley says: “Clearly we are surprised and extremely disappointed. 0¢ Sentiment: Hold Disclosure: Held Share Hi Folks Time to revisit the SPL Weekly chart. Created with Sketch. Let's not forget that this happened due to the poor performance of management that contributed to SPL getting the boot from. ASX - Day Trading Last day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sell Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based. Toll free: 1-877-388-4440 Email: CTBTaxQuestions@gov. ASX - Short Term Trading. m. Over the 3 year period the index has remained at around 40,000 whereas the SPL SP has dropped around 70%. Volume. ASX - By Stock. . 578296. Add SPL (ASX) to my watchlist (20min delay). Join the HotCopper ASX. Market . 11%. Meanwhile SPL seems to get into more schoolyard fights and then disagreements with Authority than company I have watched. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial upfront payment then a CR will definately be on the cards. 76. New Zealand Dollar. 2:00 am Eastern Standard Time Australia. IMO they haven't . . As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). The recent announcement about Viraleze nasal. , page-2. Come on SPL, complete these trials for the Companys sake, the shareholders sake and all the people out there suffering from these cancers. 52 (16th Feb) on the back of the hype that surrounded the launch of VIRALEZE in UK/EU/WORLD. 1. 0 Great. I no longer regard SPL as an investment-grade stock. Latest Posts | Join the HotCopper forum today for free, page-1. Created with Sketch. ASX - General. Comments. Last updated 15. ASX - By Stock. Latest Posts. It’s incredibly important to keep us informed. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. And that is my opinion too but about SPL. 8. opportunities galore IMO but we are likely to miss the boat again based on past performance of JF & Co. Some have been mentioned on this thread previously. 3¢ STARPHARMA HOLDINGS LIMITED - Discussion. 56% 14. Market . . 2. 8¢. 37. That won’t be a shock to. Disowned him really. Since September 2020 the. . Attached link highlights some of the complexities involved more broadly. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. 53pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on SUNRISE ENERGY METALS LIMITED. Think SPL has a valuation of 500mil…based on potential, or just promise. July 31 (Reuters) - Starpharma Holdings Ltd (SPL) : ASTRAZENECA HAS MADE DECISION TO DISCONTINUE DEVELOPMENT OF AZD0466, AFTER AN INTERNAL REVIEW. Forums. m. ASX - Day Trading. ASX - By Stock. Share Great ad I think it will boom in Hong Kong under the Banitore Manning name, despite what the naysayers say Banitore have a big presence in China their manufacturing of health products is also in China I would imagine they have significant pull in China and other regions, In my opinion Viraleze is set to be a huge world product in tome. You would think that somewhere SPL woudl have commented that TGA is awaiting data from UK trial. I recommend that everyone sees the below. Join the HotCopper ASX Stock discussion forum for STARPHARMA HOLDINGS LIMITED. Join the HotCopper ASX share market forum today for free. Don’t look to him for the truth lol. ASX - Day TradingLast day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sellThe deal, which has an initial duration of 12 months, has the same terms as the previous agreement. Provide some keywords to assist in categorisation of your abstract. Merck -- 2. ASX - General. SPL always has tantalising carrots to dangle before the eyes of investors. The main difference between shareholders and the board and their illustrious leader seems to be just in use of English language, small discrepancies like "well advanced" might me to you or I an agreement is pending, can be expected shortly, what it means to Jackie it would seem is she has undertaken a google search to see who might sell a product such as Viraleze in an particular country. Just to make sure we are all on the same page as far as AZD0466 is concerned The data available from the AACR SCLC Abstract (April 19th 2023) was from January 24th 2023 (it is out of date by more than 3 months)Fresh off the press 10th May 2023 The NHL trial is accelerating at a rapid rate Fyi 23 sites recruiting out 29 locations Since last update 8 additional. 16,161,259. The Scripps in-vivo evidence using genetically engineered mice only became available to the November TGA conference at which such matters are. Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable. and the Government Medical Research Fund which provided $1mil to SPL to aid in developing Viraleze. " Indeed. 8¢. 10/10/23. Target our investor community. Hey, "smart", I concur with your message. Follow your favourite stocks, view charts, track gainers and losers and discuss topics including politics, commodities, cryptocurrency and managed funds. Once they think they can get AZD0466 to market they will pounce if our share price is less tan $2. ASX - By Stock. . 9¢. You not understand how clinical trials works - it takes years to build regulatory packanage and do CMC. ASX - Short Term Trading. 13. Join the HotCopper ASX share market forum today for free. Last updated 15. 5¢. 0012. Last post JoeSalami. SPL Price at posting. Extract taken from recent interview with CEO of Starpharma Does it surprise you that big pharma hasn't come in and swooped in and bought the business to. comImagine what SPL's newflow and updates would look like without Viraleze. A halleluljah announcement just days before the AGM would imo be proof that investors in SPL have for years been treated like mugs. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. ASX - Day Trading. This of course is on the back of long-serving lap dog and CFO/Secretary Nigel Baade resigning around the same time that the ASX asked Starpharma questions regarding continuous disclosure obligations and also whether a SPL announcement was tantamount to ramping. Created with Sketch. $0. m. This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. ASX - Day TradingDoes Spl deserve to be seven times less in mkt cap to another biotech that has one phase 2 product spl potentially 3 and commercialisation deal with astra zeneca and collaboration deals with Merck and Genentech. Starpharma is listed on the Australian stock exchange (ASX:SPL). As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). . Fortescue Metals Group Ltd (Fortescue) is an Australia-based company engaged in iron ore. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. also not sure why anyone should get excited about a daily decrease in the short position of 0. Hey, "smart", I concur with your message. )” ~@antibotter Jan 2019 (Hotcopper post #37005569) After ASX announcement ‘Positive DEP phase 2 interim results in prostate cancer’:Peak of the UK Flu season looks to have passed . Share Many media conferences during the Pandemic we heard of Victorian initiatives for covid treatments or preventative by Dan Andrews or Brett Sutton - so VICTORIA has questions to answer. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Starpharma are 4+ years from their CRL for Vivagel and we really are none the wiser of what is going on apart from a snippet in the AGM presentation stating 'we. SPL Price at posting: 16. 0¢ Sentiment: Hold Disclosure: Held LikesSPL 7013 is already approved for use in the body (via a mucous membrane) and there would seem to be no issue as regards safety. ASX - Day TradingMelbourne, Australia; 8 December 2022: Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announces that it has commenced recruitment in the UK for a post- market clinical study of its broad-spectrum antiviral barrier nasal spray, VIRALEZETM, in patients with COVID-19, following receipt of the necessary regulatory and ethics. Last updated 15. Not going to go over all the posts that are detailing what the spl7013 antiviral nasal spray may mean to the world others have done a great job. Working in a. 1029/9/2000 SPL $0. SPL could announce tomorrow that DEP doesn’t work and they’ll still find a way to spin it positively. Last edited by sarge17 : 19/09/20 SPL Price at posting: $1. The goal of the partnership. An expat Indonesian friend did have search for me but didn't find any promotion etc a little while ago. my apologies that I could not stay after the. . ASX - General. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. ASX - By Stock. . Is the board simply resting on their collective (pre spl) laurels?Just in case you missed it HEALTHCARE Starpharma (SPL) Strong results from first in man Phase 1 DEP Docetaxel trial validate SPL’s DEP platform Safety. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Do they actually work day in day out? Do research everyday? If so why after 20 years we are still at phase 1/2. HotCopper is an Australian stock market online chat forum that allows its users to discuss financial topics. SUBMISSION STEPS. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . All the case studies have already been touted by SPL in various ASX announcements and the only trial that is declared finished by Starpharma and scheduled for readouts is DEP Cabazitaxel and that isn't until in Q3 CY2023 ,. . It is because SPL has abrogated the marketing role to its distributors. This is what faces SPL's DEP product business, and so far they seem incapable of fighting through the maze to get recognised and accepted. m. In SPL's case there is clearly another. Created with Sketch. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . MGU Magnum Mining and Exploration piecing together optimal logistics plan for Buena Vista iron ore projectI don’t hold, but depending on timing with other investments and Starpharma developments I may become a SPL holder again if the SP drops another 10-20%. . 7¢. ASX - By Stock Forum | Join the HotCopper forum today for free. “Who in at SPL made these commitments on timelines?” ~ @Joelsmith2452 CEO Jackie Fairley first told shareholders that the current Phase 2 DEP-Docetaxel trial would be complete by the end of CY2018. Forums. Join the HotCopper ASX share market forum today for free. ASX - Day TradingSo the share price of SPL rose up to a high of $2. 26. 5¢ Sentiment: Sell Disclosure: Not HeldThe one positive sign is that AstraZeneca are continuing to expand site recruitment for both AZD0466 trials. LEADING THE BATTERY METALS REVOLUTION. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Advertise on HotCopper. Hey, "smart", I concur with your message. . Time to put your feet up and kick back for a while. Interesting write-up. Charts. 70. Thanks for all your hard work and many successes during the year. To be fair the ASX has made tries on 3 recent contracts to squeeze information from SPL when didn’t want to disclose how immaterial the contracts is. 3¢. 00. Created with Sketch. SPL scientists will no doubt be working on this right now. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Norman Swan interviewed on ABC RN Breakfast talks about Covid Nasal vaccines and blockers. Click for more information. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 16,364,160. ASX - By Stock. Viraleze being 1% less efficacious against the more potent dangerous new strains is an awesome result and should be celebrated. However, the interim results from ongoing Phase One NCT04865419 (the most advanced trial) was a little underwhelming IMO. . BCSPL – VI Wave. Created with Sketch. Forex. 47pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on NOVONIX LIMITED. However, I think that maybe SPL is occasionally worth a swing trade gamble. If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. opportunities galore IMO but we are likely to miss the boat again based on past performance of JF & Co. Charts. Views. 88. This is just a lifestyle company at this point, management just keeping the company afloat with announcements that have no tangible impact on the share price while they collect their salaries. Commodities. 37pm 10/11/2023 ? HotCopper has news, discussion, prices and market data on WHISPIR LIMITED. Join the HotCopper ASX share market forum today for free. . $0. . Your post is very vague in its relationship somehow with spl, but the intent of the constant negative narrative is obvious. And somebody must be buying all the shares that are being sold. SPL has on multipleoccasions used COVID as an excuse for expanded timelines on active trails andto my understanding SPL has also been receiving support from the governmentduring COVID. Last updated 15. . Share It would be silly to be tight on cash. I remember seeing a post on SPL had 41000 views. Created with Sketch. 68. HotCopper has news, discussion, prices and market data on PROTEOMICS INTERNATIONAL LABORATORIES LTD. There appears to be a different behavioural feel about. I constantly question why I continue to subject myself to the ongoing. distraction achieved. Forums. Latest Posts. ASX - By Stock. 63. Created with Sketch. Join the HotCopper ASX share market forum today for free. 367026. So much coming up with Viraleze and DEP Starpharma team will be working very hard at the moment with so many balls in the air. ASX - Day TradingCreated with Sketch. . 0¢. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. *talks with BIG multinational Company, should've already taken place with deals completed and signed soon after the trial. bc. Forums. ASX - By Stock. Please type the title in sentence case (that is lowercase with only the first letter or the first word in capitals) and without any punctuation. Magnum Mining and Exploration Limited is an Australia-based company (ASX: MGU), which is engaged in mineral exploration and project development in Nevada, US. 24am 31/10/2023 ? Share Prices & Charts for STARPHARMA HOLDINGS LIMITED. Join the HotCopper ASX share market forum today for free. International Markets. 59pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on MESOBLAST LIMITED. CEO knows it is all going. The real story is SPL hasn't been 63 cents since 24/3/2020 that's not a 52-week low, that's a 114-week low! 2 years 3 months since its seen that price. Share Interesting and positive early pre-clinical results. Created with Sketch. 06B ! Add to my watchlist. Starpharma (SPL) Shares in the nano-biotechnology group bucked the falls in the wider market on Monday after it announced a deal with a division of US pharmaceutical giant Ely Lilly to extend the application of its technologies in the animal health area. There is potentially a multi-bagger upside if there was an exceptionally good news announcement. . Created with Sketch. most else of the list is same as we want to happen years ago and long long overdue. 5¢ STARPHARMA HOLDINGS LIMITED - Discussion. ASX - General. Created with Sketch. SPL Price at posting: 71. We know that they haven't been marketed well but i think BigPharma have had an input. Join the HotCopper ASX Stock discussion forum for STARPHARMA HOLDINGS LIMITED. 13. Below are 3 charts showing the predictions for Starpharma's Price by End 2019. Canadian Dollar. Good luck to all. 1541401. Charts.